Aros Corporation Completes Asset Sale of APACHE's Clinical Outcomes Business to Cerner Corporation

Business Wire, July 5, 2001

Business Editors

MCLEAN, Va.--(BUSINESS WIRE)--July 5, 2001

Aros Corporation, formerly APACHE Medical Systems, Inc., (OTC Bulletin Board:AMSI) today announced that it has completed the sale of substantially all of its assets and certain of its liabilities relating to the APACHE clinical outcomes business to Cerner Corporation (NASDAQ: CERN). Aros Corporation received $3.550 million in cash, subject to post-closing adjustments.

Aros has embarked on a new strategic direction focused on the medical coding business. The company acquired its first medical coding with its purchase of MetaContent, Inc., a company based in Denver, Colorado that develops and markets data management solutions for health care providers. Additionally, Aros Corporation has entered into a non-binding letter of intent for the acquisition of a second company in the medical coding business

Information about MetaContent is available at www.metacontent.net and www.hipaacode.com.

This release may contain forward-looking statements that involve a number of risks and uncertainties. It is important to note that the company's performance, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "believe," "expect," "will assist" and "anticipate," and similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: failure of the parties to consummate the proposed transactions, failure to achieve expected synergies; the Company's having sufficient sales and timely collections to meet cash requirements and achieve profitability; ability to attract and retain key employees; ability to timely develop new products and enhance existing products; ability to compete in the competitive and rapidly evolving healthcare information technology industry; ability to protect proprietary information and to obtain necessary licenses on commercially reasonable terms; and ability to comply with and adopt products and services to potential changes in government regulation. Additional discussion of these and other factors affecting the Company's business is contained in the Company's periodic filings with the Securities and Exchange Commission.

All forward-looking statements in this press release are made as of the date of the release and are based on information available to the Company's management as of the date of the release. The Company undertakes no obligation to update any statement in this release to reflect information that becomes available to the Company after the date of this release.